These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21482983)

  • 21. Peripheral neuropathy induced by oxaliplatin-based chemotherapy.
    J Support Oncol; 2006 Feb; 4(2):82-3. PubMed ID: 16499128
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety and efficacy of calcium and magnesium infusions in the chemoprevention of oxaliplatin-induced sensory neuropathy in gastrointestinal cancers.
    Xu XT; Dai ZH; Xu Q; Qiao YQ; Gu Y; Nie F; Zhu MM; Tong JL; Ran ZH
    J Dig Dis; 2013 Jun; 14(6):288-98. PubMed ID: 23432969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral sensory neuropathy--fighting cold with cold.
    Castro M
    Lancet Oncol; 2008 May; 9(5):415-6. PubMed ID: 18452855
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).
    Pachman DR; Qin R; Seisler DK; Smith EM; Beutler AS; Ta LE; Lafky JM; Wagner-Johnston ND; Ruddy KJ; Dakhil S; Staff NP; Grothey A; Loprinzi CL
    J Clin Oncol; 2015 Oct; 33(30):3416-22. PubMed ID: 26282635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics.
    Han CH; Kilfoyle DH; Hill AG; Jameson MB; McKeage MJ
    Expert Opin Drug Metab Toxicol; 2016 Dec; 12(12):1479-1490. PubMed ID: 27539508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?
    Khattak MA
    Oncologist; 2011; 16(12):1780-3. PubMed ID: 22128115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxaliplatin-related neurotoxicity: is chelation the solution?
    Hoff PM
    Nat Clin Pract Oncol; 2004 Dec; 1(2):78-9. PubMed ID: 16264824
    [No Abstract]   [Full Text] [Related]  

  • 28. [Genetic backgrounds of peripheral neuropathy induced by oxaliplatin].
    Mitsuma A; Ando Y
    Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):62-5. PubMed ID: 23391543
    [No Abstract]   [Full Text] [Related]  

  • 29. Atypical presentation of acute neurotoxicity secondary to oxaliplatin.
    Uña E
    J Oncol Pharm Pract; 2010 Dec; 16(4):280-2. PubMed ID: 20015928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
    Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
    Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity.
    Hochster HS; Grothey A; Childs BH
    J Clin Oncol; 2007 Sep; 25(25):4028-9. PubMed ID: 17664456
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of oxaliplatin-related neurotoxicity by glutathione infusions].
    Takimoto N; Sugawara S; Iida A; Sakakibara T; Mori K; Sugiura M; Yamamoto M; Tanaka M; Hayakawa T; Yamamura K; Adachi M
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2373-6. PubMed ID: 19098405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: a systematic review and meta-analysis.
    Wu Z; Ouyang J; He Z; Zhang S
    Eur J Cancer; 2012 Aug; 48(12):1791-8. PubMed ID: 22542974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients.
    Knijn N; Tol J; Koopman M; Werter MJ; Imholz AL; Valster FA; Mol L; Vincent AD; Teerenstra S; Punt CJ
    Eur J Cancer; 2011 Feb; 47(3):369-74. PubMed ID: 21067912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis].
    Junker A; Kretzschmar A; Böhm U; Tannapfel A; Langenbahn D; Pieck AC; Jaehde U
    Med Monatsschr Pharm; 2004 Oct; 27(10):349-52. PubMed ID: 15527179
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prophylactic effect of amifostine on oxaliplatin-related neurotoxicity in patients with digestive tract tumors].
    Lu P; Fan QX; Wang LX; Wang X; Zong H; Wang RL
    Ai Zheng; 2008 Oct; 27(10):1117-20. PubMed ID: 18851795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute oxaliplatin-induced peripheral-nerve hyperexcitability.
    Schmelz R; Lersch C
    J Clin Oncol; 2002 Aug; 20(16):3561-2; author reply 3562. PubMed ID: 12177120
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.
    Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC
    J Clin Oncol; 2009 Mar; 27(8):1243-9. PubMed ID: 19164207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pivotal role of intracellular calcium in oxaliplatin-induced inhibition of neurite outgrowth but not cell death in differentiated PC12 cells.
    Takeshita M; Banno Y; Nakamura M; Otsuka M; Teramachi H; Tsuchiya T; Itoh Y
    Chem Res Toxicol; 2011 Nov; 24(11):1845-52. PubMed ID: 21981408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oxaliplatin neurotoxicity].
    Gamelin L; Boisdron-Celle M; Morel A; Gamelin E
    Bull Cancer; 2006 Feb; 93 Suppl 1():S17-22. PubMed ID: 16491518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.